 - To evaluate the immunogenicity of the study vaccine in terms of seroprotection diphtheria toxoid, tetanus toxoid, poliovirus types 1, 2 and 3, Haemophilus influenzae type b Hib polysaccharide PRP, hepatitis B Hep B and vaccine response for pertussis antigens pertussis toxoid PT and filamentous haemagglutinin FHA one month after the third dose. 